At the genomic level, the externalizing PS was not related to a diagnosis of alcohol/substance use disorders (p >.23, ΔR2 = .01). As reported in this sample in Sadeh et al. (2016), the externalizing PS was associated with poorer performance on inhibitory control tasks (p =.01, ΔR2 = .05).
